Palisade Bio (PALI) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$5.2 million.
- Palisade Bio's Enterprise Value rose 3498.76% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 3498.76%. This contributed to the annual value of -$9.8 million for FY2024, which is 2100.23% up from last year.
- According to the latest figures from Q3 2025, Palisade Bio's Enterprise Value is -$5.2 million, which was up 3498.76% from -$5.4 million recorded in Q2 2025.
- Palisade Bio's 5-year Enterprise Value high stood at -$615000.0 for Q1 2021, and its period low was -$16.4 million during Q2 2023.
- Over the past 5 years, Palisade Bio's median Enterprise Value value was -$11.3 million (recorded in 2024), while the average stood at -$10.1 million.
- Data for Palisade Bio's Enterprise Value shows a peak YoY increase of 9386.84% (in 2021) and a maximum YoY decrease of 177802.93% (in 2021) over the last 5 years.
- Over the past 5 years, Palisade Bio's Enterprise Value (Quarter) stood at -$14.1 million in 2021, then grew by 12.2% to -$12.4 million in 2022, then fell by 0.4% to -$12.4 million in 2023, then grew by 21.0% to -$9.8 million in 2024, then surged by 46.78% to -$5.2 million in 2025.
- Its Enterprise Value stands at -$5.2 million for Q3 2025, versus -$5.4 million for Q2 2025 and -$7.2 million for Q1 2025.